Potential Ipriflavone and Warfarin Interaction
The American Journal of Medicine
The patient is a 68-year-old white woman with a history of atrial fibrillation, osteoporosis, and gastroesophageal reflux disease who is anticoagulated with warfarin. Her osteoporosis had been treated with risedronate sodium, but she discontinued this medication when she learned that gastroesophageal reflux was a common adverse effect. She went to a local pharmacy that specializes in herbal and nontraditional medications to seek an over-the-counter treatment for osteoporosis. The pharmacist recommended a supplement containing ipriflavone, calcium, and vitamin D.
Aged, anticoagulants, complementary therapies, drug interactions, female, humans, isoflavones, osteoporosis, warfarin
Anderson, Douglas C. and Scoggins, B. P., "Potential Ipriflavone and Warfarin Interaction" (2007). Pharmacy Practice Faculty Publications. 155.